Lilia-Celine Lozada
Stock Analyst at JP Morgan
(1.81)
# 3,297
Out of 5,154 analysts
9
Total ratings
40%
Success rate
8.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $22 → $26 | $26.86 | -3.20% | 2 | Feb 6, 2026 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $30.02 | +59.89% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $12.74 | -5.81% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $1.43 | +249.65% | 2 | Nov 7, 2025 |
Envista Holdings
Feb 6, 2026
Maintains: Neutral
Price Target: $22 → $26
Current: $26.86
Upside: -3.20%
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $30.02
Upside: +59.89%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $12.74
Upside: -5.81%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $1.43
Upside: +249.65%